Chameleon CH06-40-75USRecalls & reported problems
Mozarc Medical US LLC · PTA Balloon Catheter with Injection Port · Class 2
All models of Chameleon (7)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10884521812277), received between Jun 30, 2023 and Jul 27, 2023 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Recalls naming this device
- Sep 19, 2024Open, Classified
Specific lots of the Chameleon PTA Balloon Catheter failed to meet in-house balloon pressure testing.
Z-0257-2025 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Burst Container or Vessel1
- Fracture1
- Leak/Splash1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Insufficient Information1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 27, 2023Fracture; Leak/Splash; Fracture; Leak/Splash
ACCORDING TO THE REPORTER, WHEN THE CONTRAST MEDIUM WAS INJECTED THROUGH THE INJECTION PORT, THE CONTRAST MEDIUM LEAKED FROM A PORTION OTHER THAN THE DRAINAGE HOLE. THERE WAS A LEAK AT THE CATHETER SHAFT. THERE WAS NO LUER ADAPTER PROBLEM. THERE WAS NOTHING UNUSUAL OBSERVED ON THE DEVICE PRIOR TO USE. THERE WAS NO RESISTANCE ENCOUNTERED WHEN ADVANCING THE DEVICE. TEGO WAS NOT UTILIZED, AND THE INSERTION SITE WAS NOT HANDLED PRIOR TO PRODUCT PLACEMENT. INTERVENTION/TREATMENT WAS NOT REQUIRED AS A RESULT OF THE EVENT. AS A REMEDIAL ACTION THE CATHETER WAS REMOVED AND REPLACED. THE PROCEDURE WAS COMPLETED. THE PATIENT DID NOT HAVE ANY SYMPTOMS OR COMPLICATIONS RELATED TO THIS EVENT. THERE WAS NO BLOOD LOSS AND BLOOD TRANSFUSION WAS NOT REQUIRED DUE TO THE EVENT. MOZARC PERFORMED AN EVALUATION OF THE REPORTED CATHETER AND THE INITIAL EVALUATION OF THE INCIDENT DEVICE FOUND THAT VISUAL INSPECTION OF THE DEVICE NOTED THAT THERE WAS A CRACK ON THE LUER PORT FOR THE CONTRAST MEDIA. THE CRACK LEAKED WHEN THE PORT WAS FLUSHED WITH WATER. THE PACKAGING WAS NOT RETURNED, SO THE ROOT CAUSE OF THE OBSERVED DAMAGE COULD NOT BE RELIABLY DETERMINED, HOWEVER ALL DEVICES ARE TESTED FOR LE AKS BEFORE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17402805 ↗MalfunctionJun 30, 2023Burst Container or Vessel; Burst Container or Vessel
ACCORDING TO THE REPORTER, WHEN ADVANCING THE DEVICE ON FIRST ATTEMPT, RESISTANCE ENCOUNTERED. AFTER FIRST INFLATION UP TO 14 ATMS ( ATMOSPHERE), THE PRODUCT'S BALLOON HAD BURST BEFORE THE RATED BURST PRESSURE WAS REACHED, HAD TORN AND WAS TEARING AT THE CONNECTION SITE NEXT TO WHERE THE SILVER PORT OPENING WAS (ON THE FRONT END OF THE BALLOON) BUT THE BALLOON DID NOT COMPLETELY SEPARATE FROM THE SHAFT AND NO PORTION OF DEVICE FELL IN PATIENT. THE CONNECTION ISSUE WAS AT THE SILVER PORT AND BALLOON. THE BACK END ¿HUB¿ WAS FINE. 7 FR COMPETITOR'S INTRODUCER SHEATH WAS USED. THE SIZE OF GUIDEWIRE WAS .035. THERE WAS NO ISSUE WITH THE HUB OR LUER. NO EXCESSIVE FORCE USED. NOTHING UNUSUAL OBSERVED ON THE DEVICE PRIOR TO USE. NO OTHER PRODUCTS BEING UTILIZED WITH THE DEVICE. THE BALLOON WAS INFLATED BY INFLATION DEVICE. FLUSHING WAS NOT PERFORMED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. NO CLEANING AGENT USED ON THE DEVICE. THEY REMOVED OR PULLED OUT THE PRODUCT FROM PATIENT THROUGH THE SHEATH BEFORE TOO MUCH BLOOD LOSS AS REMEDIAL ACTION TO ADDRESS THE ISSUE. THE PROCEDURE WAS COMPLETED WITH COMPETITOR'S BALLOON. THERE WAS UNSPECIFIED AMOUNT OF BLOOD LOSS. BLOOD TR
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions
MAUDE report 17237639 ↗
Other Catheter, Angioplasty, Peripheral, Transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page